We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

2019 COG/ASPHO Joint Session: Pediatric Precision Oncology: MATCH and Beyond

1. Name and Credentials (as you would like it to appear on your CME certificate): *This question is required.

2. E-mail Address: *This question is required. This question requires a valid email address.

3. How valuable is the content of this session for you? *This question is required.

4. Objectives:

Discuss molecular testing strategies utilized for tumor and germline testing in precision oncology trials and practical challenges of such testing for childhood cancer patients
Explain results of tumor testing for identification of actionable mutations in the pediatric and adult MATCH trials and their implications for cancer treatment strategies
Describe the strategies used for selection of targeted therapies in Pediatric MATCH and the development of future precision oncology trials
Recognize practical and ethical aspects of germline testing in pediatric clinical trials, as well as opportunities for improved clinical care of patients and families

Please rate your level of agreement with the following statement:
Presenters met stated learning objectives *This question is required.

5. Speaker Evaluation
Please rate your level of agreement for each speaker on the following:

Presenter was effective *This question is required.

Space Cell	Strongly Agree	Moderately Agree	Neither Agree nor Disagree	Moderately Disagree	Strongly Disagree	N/A
Naomi Winick, MD	Naomi Winick, MD: Strongly Agree	Naomi Winick, MD: Moderately Agree	Naomi Winick, MD: Neither Agree nor Disagree	Naomi Winick, MD: Moderately Disagree	Naomi Winick, MD: Strongly Disagree	Naomi Winick, MD: N/A
Donald Parsons, MD PhD	Donald Parsons, MD PhD: Strongly Agree	Donald Parsons, MD PhD: Moderately Agree	Donald Parsons, MD PhD: Neither Agree nor Disagree	Donald Parsons, MD PhD: Moderately Disagree	Donald Parsons, MD PhD: Strongly Disagree	Donald Parsons, MD PhD: N/A
Julia Glade Bender, MD	Julia Glade Bender, MD: Strongly Agree	Julia Glade Bender, MD: Moderately Agree	Julia Glade Bender, MD: Neither Agree nor Disagree	Julia Glade Bender, MD: Moderately Disagree	Julia Glade Bender, MD: Strongly Disagree	Julia Glade Bender, MD: N/A
Nita Seibel, MD	Nita Seibel, MD: Strongly Agree	Nita Seibel, MD: Moderately Agree	Nita Seibel, MD: Neither Agree nor Disagree	Nita Seibel, MD: Moderately Disagree	Nita Seibel, MD: Strongly Disagree	Nita Seibel, MD: N/A
Sharon Plon, MD PhD	Sharon Plon, MD PhD: Strongly Agree	Sharon Plon, MD PhD: Moderately Agree	Sharon Plon, MD PhD: Neither Agree nor Disagree	Sharon Plon, MD PhD: Moderately Disagree	Sharon Plon, MD PhD: Strongly Disagree	Sharon Plon, MD PhD: N/A
Steven Joffe, MD MPH	Steven Joffe, MD MPH: Strongly Agree	Steven Joffe, MD MPH: Moderately Agree	Steven Joffe, MD MPH: Neither Agree nor Disagree	Steven Joffe, MD MPH: Moderately Disagree	Steven Joffe, MD MPH: Strongly Disagree	Steven Joffe, MD MPH: N/A
Anita Villani, MD MSc FRCPC	Anita Villani, MD MSc FRCPC: Strongly Agree	Anita Villani, MD MSc FRCPC: Moderately Agree	Anita Villani, MD MSc FRCPC: Neither Agree nor Disagree	Anita Villani, MD MSc FRCPC: Moderately Disagree	Anita Villani, MD MSc FRCPC: Strongly Disagree	Anita Villani, MD MSc FRCPC: N/A

6. Demonstrated expertise in content area *This question is required.

Space Cell	Strongly Agree	Moderately Agree	Neither Agree nor Disagree	Moderately Disagree	Strongly Disagree	N/A
Naomi Winick, MD	Naomi Winick, MD: Strongly Agree	Naomi Winick, MD: Moderately Agree	Naomi Winick, MD: Neither Agree nor Disagree	Naomi Winick, MD: Moderately Disagree	Naomi Winick, MD: Strongly Disagree	Naomi Winick, MD: N/A
Donald Parsons, MD PhD	Donald Parsons, MD PhD: Strongly Agree	Donald Parsons, MD PhD: Moderately Agree	Donald Parsons, MD PhD: Neither Agree nor Disagree	Donald Parsons, MD PhD: Moderately Disagree	Donald Parsons, MD PhD: Strongly Disagree	Donald Parsons, MD PhD: N/A
Julia Glade Bender, MD	Julia Glade Bender, MD: Strongly Agree	Julia Glade Bender, MD: Moderately Agree	Julia Glade Bender, MD: Neither Agree nor Disagree	Julia Glade Bender, MD: Moderately Disagree	Julia Glade Bender, MD: Strongly Disagree	Julia Glade Bender, MD: N/A
Nita Seibel, MD	Nita Seibel, MD: Strongly Agree	Nita Seibel, MD: Moderately Agree	Nita Seibel, MD: Neither Agree nor Disagree	Nita Seibel, MD: Moderately Disagree	Nita Seibel, MD: Strongly Disagree	Nita Seibel, MD: N/A
Sharon Plon, MD PhD	Sharon Plon, MD PhD: Strongly Agree	Sharon Plon, MD PhD: Moderately Agree	Sharon Plon, MD PhD: Neither Agree nor Disagree	Sharon Plon, MD PhD: Moderately Disagree	Sharon Plon, MD PhD: Strongly Disagree	Sharon Plon, MD PhD: N/A
Steven Joffe, MD MPH	Steven Joffe, MD MPH: Strongly Agree	Steven Joffe, MD MPH: Moderately Agree	Steven Joffe, MD MPH: Neither Agree nor Disagree	Steven Joffe, MD MPH: Moderately Disagree	Steven Joffe, MD MPH: Strongly Disagree	Steven Joffe, MD MPH: N/A
Anita Villani, MD MSc FRCPC	Anita Villani, MD MSc FRCPC: Strongly Agree	Anita Villani, MD MSc FRCPC: Moderately Agree	Anita Villani, MD MSc FRCPC: Neither Agree nor Disagree	Anita Villani, MD MSc FRCPC: Moderately Disagree	Anita Villani, MD MSc FRCPC: Strongly Disagree	Anita Villani, MD MSc FRCPC: N/A

7. Presentation was scientifically rigorous, balanced, and free of commercial bias *This question is required.

Space Cell	Strongly Agree	Moderately Agree	Neither Agree nor Disagree	Moderately Disagree	Strongly Disagree	N/A
Naomi Winick, MD	Naomi Winick, MD: Strongly Agree	Naomi Winick, MD: Moderately Agree	Naomi Winick, MD: Neither Agree nor Disagree	Naomi Winick, MD: Moderately Disagree	Naomi Winick, MD: Strongly Disagree	Naomi Winick, MD: N/A
Donald Parsons, MD PhD	Donald Parsons, MD PhD: Strongly Agree	Donald Parsons, MD PhD: Moderately Agree	Donald Parsons, MD PhD: Neither Agree nor Disagree	Donald Parsons, MD PhD: Moderately Disagree	Donald Parsons, MD PhD: Strongly Disagree	Donald Parsons, MD PhD: N/A
Julia Glade Bender, MD	Julia Glade Bender, MD: Strongly Agree	Julia Glade Bender, MD: Moderately Agree	Julia Glade Bender, MD: Neither Agree nor Disagree	Julia Glade Bender, MD: Moderately Disagree	Julia Glade Bender, MD: Strongly Disagree	Julia Glade Bender, MD: N/A
Nita Seibel, MD	Nita Seibel, MD: Strongly Agree	Nita Seibel, MD: Moderately Agree	Nita Seibel, MD: Neither Agree nor Disagree	Nita Seibel, MD: Moderately Disagree	Nita Seibel, MD: Strongly Disagree	Nita Seibel, MD: N/A
Sharon Plon, MD PhD	Sharon Plon, MD PhD: Strongly Agree	Sharon Plon, MD PhD: Moderately Agree	Sharon Plon, MD PhD: Neither Agree nor Disagree	Sharon Plon, MD PhD: Moderately Disagree	Sharon Plon, MD PhD: Strongly Disagree	Sharon Plon, MD PhD: N/A
Steven Joffe, MD MPH	Steven Joffe, MD MPH: Strongly Agree	Steven Joffe, MD MPH: Moderately Agree	Steven Joffe, MD MPH: Neither Agree nor Disagree	Steven Joffe, MD MPH: Moderately Disagree	Steven Joffe, MD MPH: Strongly Disagree	Steven Joffe, MD MPH: N/A
Anita Villani, MD MSc FRCPC	Anita Villani, MD MSc FRCPC: Strongly Agree	Anita Villani, MD MSc FRCPC: Moderately Agree	Anita Villani, MD MSc FRCPC: Neither Agree nor Disagree	Anita Villani, MD MSc FRCPC: Moderately Disagree	Anita Villani, MD MSc FRCPC: Strongly Disagree	Anita Villani, MD MSc FRCPC: N/A

8. Identify how you will change your practice as a result of attending this activity (select all that apply). *This question is required.

This activity validated my current practice; no changes will be made
Create/revise protocols, policies, and/or procedures
Change the management and/or treatment of my patients
Other (please specify) Please enter an 'other' value for this selection.

9. Specifically, what change(s) do you intend to make? *This question is required.

10. Other comments regarding the session: